$37.65
3.01% yesterday
Nasdaq, Dec 02, 10:00 pm CET
ISIN
US92346J1088
Symbol
VCEL

Vericel Corporation Stock price

$37.65
+0.95 2.57% 1M
-2.81 6.95% 6M
-17.26 31.43% YTD
-21.09 35.90% 1Y
+13.80 57.86% 3Y
+12.77 51.33% 5Y
+35.44 1,603.62% 10Y
-299.95 88.85% 20Y
Nasdaq, Closing price Tue, Dec 02 2025
-1.17 3.01%

Key metrics

Basic
Market capitalization
$1.9b
Enterprise Value
$1.8b
Net debt
positive
Cash
$135.4m
Shares outstanding
50.6m
Valuation (TTM | estimate)
P/E
150.6 | 167.8
P/S
7.4 | 6.8
EV/Sales
6.8 | 6.3
EV/FCF
86.8
P/B
5.9
Financial Health
Equity Ratio
67.5%
Return on Equity
3.6%
ROCE
1.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$258.7m | $280.8m
EBITDA
$17.0m | $72.5m
EBIT
$7.1m | $7.6m
Net Income
$13.1m | $11.3m
Free Cash Flow
$20.4m
Growth (TTM | estimate)
Revenue
14.1% | 18.4%
EBITDA
331.4% | 623.2%
EBIT
678.4% | 69.2%
Net Income
268.5% | 9.5%
Free Cash Flow
269.6%
Margin (TTM | estimate)
Gross
73.8%
EBITDA
6.6% | 25.8%
EBIT
2.8%
Net
5.1% | 4.0%
Free Cash Flow
7.9%
More
EPS
$0.3
FCF per Share
$0.4
Short interest
11.5%
Employees
357
Rev per Employee
$660.0k
Show more

Is Vericel Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,078 stocks worldwide.

Vericel Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Vericel Corporation forecast:

12x Buy
86%
2x Hold
14%

Analyst Opinions

14 Analysts have issued a Vericel Corporation forecast:

Buy
86%
Hold
14%

Financial data from Vericel Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
259 259
14% 14%
100%
- Direct Costs 68 68
5% 5%
26%
191 191
18% 18%
74%
- Selling and Administrative Expenses 159 159
14% 14%
61%
- Research and Development Expense 25 25
2% 2%
10%
17 17
331% 331%
7%
- Depreciation and Amortization 9.93 9.93
92% 92%
4%
EBIT (Operating Income) EBIT 7.11 7.11
678% 678%
3%
Net Profit 13 13
268% 268%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Vericel Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Vericel Corporation Stock News

Neutral
GlobeNewsWire
19 days ago
CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside chat at the Stephens Annual Investment Conference at 11:00 a.m. ET (10:00 a.m. CT) on Thursday, November 20, 2025.
Neutral
Seeking Alpha
26 days ago
Vericel Corporation ( VCEL ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Eric Burns - Vice President of Finance & Investor Relations Dominick C. Colangelo - CEO, President & Director Joseph Mara - CFO & Treasurer Conference Call Participants Joshua Jennings - TD Cowen, Research Division Richard Newitter - Truist Securities, Inc., Research Division Ryan Zimmerman - BT...
Neutral
The Motley Fool
27 days ago
Baltimore-based Brown Capital Management sold 861,020 shares of Vericel Corporation in the third quarter for an estimated $31 million. The transaction value represented 1.3% of Brown Capital's 13F reportable AUM as of quarter-end.
More Vericel Corporation News

Company Profile

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Head office United States
CEO Dominick Colangelo
Employees 357
Founded 1989
Website vcel.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today